Overview

Pharmacokinetics of Oral Calcium Carbonate in Parturients

Status:
NOT_YET_RECRUITING
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
This study investigates the time course of change in calcium in the blood after a pregnant subject takes an oral dose of calcium carbonate (commonly marketed as "Tums"). This information is important for trials investigating whether calcium can reduce postpartum hemorrhage, bleeding after delivery.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Stanford University
Treatments:
Calcium Carbonate